Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1965 Nov;49(11):573–590. doi: 10.1136/bjo.49.11.573

Electro-oculogram findings in patients treated with antimalarial drugs.

H Kolb
PMCID: PMC506163  PMID: 5849422

Full text

PDF
590

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARDEN G. B., FOJAS M. R. Electrophysiological abnormalities in pigmentary degenerations of the retina. Assessment of value and basis. Arch Ophthalmol. 1962 Sep;68:369–389. doi: 10.1001/archopht.1962.00960030373012. [DOI] [PubMed] [Google Scholar]
  2. ARDEN G. B., FRIEDMANN A., KOLB H. Anticipation of chloroquine retinopathy. Lancet. 1962 Jun 2;1(7240):1164–1165. doi: 10.1016/s0140-6736(62)92200-6. [DOI] [PubMed] [Google Scholar]
  3. ARDEN G. B., KELSEY J. H. Some observations on the relationship between the standing potential of the human eye and the bleaching and regeneration of visual purple. J Physiol. 1962 May;161:205–226. doi: 10.1113/jphysiol.1962.sp006882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Arden G. B., Barrada A. Analysis of the electro-oculograms of a series of normal subjects: role of the lens in the development of the standing potential. Br J Ophthalmol. 1962 Aug;46(8):468–482. doi: 10.1136/bjo.46.8.468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Arden G. B., Barrada A., Kelsey J. H. New clinical test of retinal function based upon the standing potential of the eye. Br J Ophthalmol. 1962 Aug;46(8):449–467. doi: 10.1136/bjo.46.8.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. BERNSTEIN H. N., GINSBERG J. THE PATHOLOGY OF CHLOROQUINE RETINOPATHY. Arch Ophthalmol. 1964 Feb;71:238–245. doi: 10.1001/archopht.1964.00970010254019. [DOI] [PubMed] [Google Scholar]
  7. BERNSTEIN H., ZVAIFLER N., RUBIN M., MANSOUR A. M. THE OCULAR DEPOSITION OF CHLOROQUINE. Invest Ophthalmol. 1963 Aug;2:384–392. [PubMed] [Google Scholar]
  8. CALKINS L. L. Corneal epithelial changes occurring during chloroquine (aralen) therapy. AMA Arch Ophthalmol. 1958 Dec;60(6):981–988. doi: 10.1001/archopht.1958.00940081001001. [DOI] [PubMed] [Google Scholar]
  9. CAMBIAGGI A. Unusual ocular lesions in a case of systemic lupus erythematosus. AMA Arch Ophthalmol. 1957 Mar;57(3):451–453. doi: 10.1001/archopht.1957.00930050463019. [DOI] [PubMed] [Google Scholar]
  10. ELLSWORTH R. J., ZELLER R. W. Chloroquine (Aralen)-induced retinal damage. Arch Ophthalmol. 1961 Aug;66:269–272. doi: 10.1001/archopht.1961.00960010271019. [DOI] [PubMed] [Google Scholar]
  11. GOURAS P., GUNKEL R. D. THE EOG IN CHLOROQUINE AND OTHER RETINOPATHIES. Arch Ophthalmol. 1963 Nov;70:629–639. doi: 10.1001/archopht.1963.00960050631009. [DOI] [PubMed] [Google Scholar]
  12. HENKIND P., CARR R. E., SIEGEL I. M. EARLY CHLOROQUINE RETINOPATHY: CLINICAL AND FUNCTIONAL FINDINGS. Arch Ophthalmol. 1964 Feb;71:157–165. doi: 10.1001/archopht.1964.00970010173003. [DOI] [PubMed] [Google Scholar]
  13. HENKIND P., ROTHFIELD N. F. Ocular abnormalities in patients treated with synthetic antimalarial drugs. N Engl J Med. 1963 Aug 29;269:433–439. doi: 10.1056/NEJM196308292690901. [DOI] [PubMed] [Google Scholar]
  14. HOBBS H. E., CALNAN C. D. The ocular complications of chloroquine therapy. Lancet. 1958 Jun 7;1(7032):1207–1209. doi: 10.1016/s0140-6736(58)91911-1. [DOI] [PubMed] [Google Scholar]
  15. HOBBS H. E., CALNAN C. D. Visual disturbances with antimalarial drugs, with particular reference to chloroquine keratopathy. Arch Dermatol. 1959 Nov;80:557–563. doi: 10.1001/archderm.1959.01560230043008. [DOI] [PubMed] [Google Scholar]
  16. HOBBS H. E., SORSBY A., FREEDMAN A. Retinopathy following chloroquine therapy. Lancet. 1959 Oct 3;2(7101):478–480. doi: 10.1016/s0140-6736(59)90604-x. [DOI] [PubMed] [Google Scholar]
  17. Hobbs H. E., Eadie S. P., Somerville F. OCULAR LESIONS AFTER TREATMENT WITH CHLOROQUINE. Br J Ophthalmol. 1961 Apr;45(4):284–297. doi: 10.1136/bjo.45.4.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. KERSLEY G. D., PALIN A. G. Amodiaquine and hydroxychloroquine in rheumatoid arthritis. Lancet. 1959 Nov 21;2(7108):886–888. doi: 10.1016/s0140-6736(59)90808-6. [DOI] [PubMed] [Google Scholar]
  19. OKUN E., GOURAS P., BERNSTEIN H., VON SALLMANN L. Chloroquine retinopathy; a report of eight cases with ERG and dark-adaptation findings. Arch Ophthalmol. 1963 Jan;69:59–71. doi: 10.1001/archopht.1963.00960040065013. [DOI] [PubMed] [Google Scholar]
  20. REBELLO D. J. Ocular reactions to antimalarial drugs. Arch Dermatol. 1961 May;83:785–789. doi: 10.1001/archderm.1961.01580110073011. [DOI] [PubMed] [Google Scholar]
  21. ROGERS P. A. The cornea and chloroquine. Aust J Dermatol. 1959 Aug;5:10–11. doi: 10.1111/j.1440-0960.1959.tb01562.x. [DOI] [PubMed] [Google Scholar]
  22. SCHMIDT B., MUELLER-LIMMROTH W. Electroretinographic examinations following the application of chloroquine. Acta Ophthalmol Suppl. 1962;Suppl 70:245–251. doi: 10.1111/j.1755-3768.1962.tb00327.x. [DOI] [PubMed] [Google Scholar]
  23. WETTERHOLM D. H., WINTER F. C. HISTOPATHOLOGY OF CHLOROQUINE RETINAL TOXICITY. Arch Ophthalmol. 1964 Jan;71:82–87. doi: 10.1001/archopht.1964.00970010098016. [DOI] [PubMed] [Google Scholar]
  24. ZELLER R. W., DEERING D. Corneal complication of chloroquine (aralen) phosphate therapy. J Am Med Assoc. 1958 Dec 27;168(17):2263–2264. doi: 10.1001/jama.1958.63000170007012b. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES